Development of Tissue Bank of Blood, Urine, and Bone Marrow from Patients with B-Chronic Lymphocytic Leukemia (B-CLL)

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 1827-00
    Sponsor Protocol Number: 1827-00

About this study

This study is being done to find biologic abnormalities in the lymphocyte cells of patients with CLL (Chronic Lymphocytic Leukemia). In order to validate these tests, cells from patients with CLL will be studied when the tests are ready in the laboratory. This study is also being done to learn more about the environmental and genetic factors that might be responsible for CLL. Finding such factors would help us understand the causes and possible prevention of this cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Patients with early stage chronic lymphocytic leukemia (B-CLL) as well as individuals with the precursor state monoclonal B-cell lymphocytosis (MBL)
  • Patients who have more advanced stages of CLL
  • Patients who have been treated for progressive CLL
  • Patients who have been treated and have relapsed/refractory CLL

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Neil Kay, M.D.

Open for enrollment

Contact information:

Julianne Lunde M.A.

(507)266-2657

Lunde.Julianne@mayo.edu

.
CLS-20315017

Mayo Clinic Footer